A Nutrient Approach to Prostate Cancer Prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)

REFERENCES

• Taylor , P R and Greenwald , P . 2005 . Nutritional interventions in cancer prevention . J Clin Oncol , 23 : 333 – 345 .
   PubMed Web of Science ®Google Scholar
• Greenwald , P , Anderson , D , Nelson , S A and Taylor , P R . 2007 . Clinical trials of vitamin and mineral supplements for cancer prevention . Am J Clin Nutr , 85 : 314S – 317S .
   PubMed Web of Science ®Google Scholar
• Kucuk , O . 2002 . Chemoprevention of prostate cancer . Cancer Metastasis Rev , 21 : 111 – 124 .
   PubMed Web of Science ®Google Scholar
• Siddiqui , I A , Afaq , F , Adhami , V M and Mukhtar , H . 2008 . Prevention of prostate cancer through custom tailoring of chemopreventive regimen . Chem Biol Interact , 171 : 122 – 132 .
   PubMed Web of Science ®Google Scholar
• Syed , D N , Khan , N , Afaq , F and Mukhtar , H . 2007 . Chemoprevention of prostate cancer through dietary agents: progress and promise . Cancer Epidemiol Biomarkers Prev , 16 : 2193 – 2203 .
   PubMed Web of Science ®Google Scholar
• Jemal , A , Siegel , R , Xu , J and Ward , E . 2010 . Cancer statistics . CA Cancer J Clin , 60 : 1 – 24 . 2010
   PubMed Web of Science ®Google Scholar
• Potosky , A L , Legler , J , Albertsen , P C , Stanford , J L Gilliland , F D . 2000 . Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study . J Natl Cancer Inst , 92 : 1582 – 1592 .
   PubMed Web of Science ®Google Scholar
• Hsing , A W , Reichardt , J K and Stanczyk , F Z . 2002 . Hormones and prostate cancer: current perspectives and future directions . Prostate , 52 : 213 – 235 .
   PubMedGoogle Scholar
• Ross , R K , Makridakis , N M and Reichardt , J K . 2003 . Prostate Cancer: Epidemiology and Molecular Endocrinology. , Oxford, , England : Oxford University Press .
   Google Scholar
• Thompson , I M , Goodman , P J , Tangen , C M , Lucia , M S Miller , G J . 2003 . The influence of finasteride on the development of prostate cancer . N Engl J Med , 349 : 215 – 224 .
   PubMed Web of Science ®Google Scholar
• Lucia , M S , Epstein , J I , Goodman , P J , Darke , A K Reuter , V E . 2007 . Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial . J Natl Cancer Inst , 99 : 1375 – 1383 .
   PubMed Web of Science ®Google Scholar
• Dunn , B K , Ryan , A and Ford , L G . 2009 . Selenium and Vitamin E Cancer Prevention Trial: a nutrient approach to prostate cancer prevention . Recent Results Cancer Res , 181 : 183 – 193 .
   PubMedGoogle Scholar
• Ip , C . 1998 . Lessons from basic research in selenium and cancer prevention . J Nutr , 128 : 1845 – 1854 .
   PubMed Web of Science ®Google Scholar
• Raich , P C , Lu , J , Thompson , H J and Combs , G F Jr. 2001 . Selenium in cancer prevention: clinical issues and implications . Cancer Invest , 19 : 540 – 553 .
   PubMed Web of Science ®Google Scholar
• El-Bayoumy , K and Sinha , R . 2005 . Molecular chemoprevention by selenium: a genomic approach . Mutat Res , 591 : 224 – 236 .
   PubMed Web of Science ®Google Scholar
• Kim , Y S and Milner , J . 2001 . Molecular targets for selenium in cancer prevention . Nutr Cancer , 40 : 50 – 54 .
   PubMed Web of Science ®Google Scholar
• Lu , J and Holmgren , A . 2009 . Selenoproteins. . J Biol Chem , 284 : 723 – 727 .
   PubMed Web of Science ®Google Scholar
• Schrauzer , G N . 2001 . Nutritional selenium supplements: product types, quality, and safety . J Am Coll Nutr , 20 : 1 – 4 .
   PubMed Web of Science ®Google Scholar
• National Research Council . 1989 . Subcommittee on the Tenth Edition of the RDAs. , Washington, DC : National Academy Press .
   Google Scholar
• Milner , J A . 1985 . Effect of selenium on virally induced and transplantable tumor models . Fed Proc , 44 : 2568 – 2572 .
   PubMedGoogle Scholar
• Webber , M M , Perez-Ripoll , E A and James , G T . 1985 . Inhibitory effects of selenium on the growth of DU-145 human prostate carcinoma cells in vitro . Biochem Biophys Res Commun , 130 : 603 – 609 .
   PubMed Web of Science ®Google Scholar
• Reagan-Shaw , S , Nihal , M , Ahsan , H , Mukhtar , H and Ahmad , N . 2008 . Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio . Prostate , 68 : 1624 – 1634 .
   PubMed Web of Science ®Google Scholar
• Gundimeda , U , Schiffman , J E , Chhabra , D , Wong , J Wu , A . 2008 . Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: relevance to selenium-induced apoptosis in prostate cancer cells . J Biol Chem , 283 : 34519 – 34531 .
   PubMed Web of Science ®Google Scholar
• Kretz-Remy , C , Mehlen , P , Mirault , M E and Arrigo , A P . 1996 . Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression . J Cell Biol , 133 : 1083 – 1093 .
   PubMed Web of Science ®Google Scholar
• Brigelius-Flohe , R , Friedrichs , B , Maurer , S , Schultz , M and Streicher , R . 1997 . Interleukin-1-induced nuclear factor kappa B activation is inhibited by overexpression of phospholipid hydroperoxide glutathione peroxidase in a human endothelial cell line . Biochem J , 328 ( Pt 1 ) : 199 – 203 .
   PubMed Web of Science ®Google Scholar
• Hoffmann , P R . 2007 . Mechanisms by which selenium influences immune responses . Arch Immunol Ther Exp (Warsz) , 55 : 289 – 297 .
   PubMed Web of Science ®Google Scholar
• Hoffmann , P R and Berry , M J . 2008 . The influence of selenium on immune responses . Mol Nutr Food Res , 52 : 1273 – 1280 .
   PubMed Web of Science ®Google Scholar
• Shrimali , R K , Irons , R D , Carlson , B A , Sano , Y Gladyshev , V N . 2008 . Selenoproteins mediate T cell immunity through an antioxidant mechanism . J Biol Chem , 283 : 20181 – 20185 .
   PubMed Web of Science ®Google Scholar
• Curran , J E , Jowett , J B , Elliott , K S , Gao , Y Gluschenko , K . 2005 . Genetic variation in selenoprotein S influences inflammatory response . Nat Genet , 37 : 1234 – 1241 .
   PubMed Web of Science ®Google Scholar
• Klein , E A , Thompson , I M , Lippman , S M , Goodman , P J Albanes , D . 2000 . SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and design . Prostate Cancer Prostatic Dis , 3 : 145 – 151 .
   PubMed Web of Science ®Google Scholar
• Klein , E A , Thompson , I M , Lippman , S M , Goodman , P J Albanes , D . 2001 . SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial . J Urol , 166 : 1311 – 1315 .
   PubMed Web of Science ®Google Scholar
• Menter , D G , Sabichi , A L and Lippman , S M . 2000 . Selenium effects on prostate cell growth . Cancer Epidemiol Biomarkers Prev , 9 : 1171 – 1182 .
   PubMed Web of Science ®Google Scholar
• Jiang , W , Jiang , C , Pei , H , Wang , L Zhang , J . 2009 . In vivo molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: lack of involvement of GADD genes . Mol Cancer Ther , 8 : 682 – 691 .
   PubMed Web of Science ®Google Scholar
• Yamaguchi , K , Uzzo , R G , Pimkina , J , Makhov , P Golovine , K . 2005 . Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis . Oncogene , 24 : 5868 – 5877 .
   PubMed Web of Science ®Google Scholar
• Lu , J , Jiang , C , Kaeck , M , Ganther , H Vadhanavikit , S . 1995 . Dissociation of the genotoxic and growth inhibitory effects of selenium . Biochem Pharmacol , 50 : 213 – 219 .
   PubMed Web of Science ®Google Scholar
• Seo , Y R , Kelley , M R and Smith , M L . 2002 . Selenomethionine regulation of p53 by a ref1-dependent redox mechanism . Proc Natl Acad Sci USA , 99 : 14548 – 14553 .
   PubMed Web of Science ®Google Scholar
• Lee , S O , Yeon Chun , J , Nadiminty , N , Trump , D L Ip , C . 2006 . Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA) . Prostate , 66 : 1070 – 1075 .
   PubMed Web of Science ®Google Scholar
• Dong , Y , Zhang , H , Hawthorn , L , Ganther , H E and Ip , C . 2003 . Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array . Cancer Res , 63 : 52 – 59 .
   PubMed Web of Science ®Google Scholar
• Zhao , H and Brooks , J D . 2007 . Selenomethionine induced transcriptional programs in human prostate cancer cells . J Urol , 177 : 743 – 750 .
   PubMed Web of Science ®Google Scholar
• Schrauzer , G N . 1976 . Selenium and cancer: a review . Bioinorg Chem , 5 : 275 – 281 .
   PubMedGoogle Scholar
• Nakamura , A , Shirai , T , Takahashi , S , Ogawa , K Hirose , M . 1991 . Lack of modification by naturally occurring antioxidants of 3,2′-dimethyl-4-aminobiphenyl-initiated rat prostate carcinogenesis . Cancer Lett , 58 : 241 – 246 .
   PubMed Web of Science ®Google Scholar
• Shamberger , R J and Frost , D V . 1969 . Possible protective effect of selenium against human cancer . Can Med Assoc J , 100 : 682
   PubMed Web of Science ®Google Scholar
• Schrauzer , G N . 2000 . Anticarcinogenic effects of selenium . Cell Mol Life Sci , 57 : 1864 – 1873 .
   PubMed Web of Science ®Google Scholar
• Yoshizawa , K , Willett , W C , Morris , S J , Stampfer , M J Spiegelman , D . 1998 . Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer . J Natl Cancer Inst , 90 : 1219 – 1224 .
   PubMed Web of Science ®Google Scholar
• Allen , N E , Appleby , P N , Roddam , A W , Tjonneland , A Johnsen , N F . 2008 . Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) . Am J Clin Nutr , 88 : 1567 – 1575 .
   PubMed Web of Science ®Google Scholar
• Gill , J K , Franke , A A , Steven Morris , J , Cooney , R V Wilkens , L R . 2009 . Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort . Cancer Causes Control , 20 : 1161 – 1171 .
   PubMed Web of Science ®Google Scholar
• Yu , S Y , Zhu , Y J and Li , W G . 1997 . Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong . Biol Trace Elem Res , 56 : 117 – 124 .
   PubMed Web of Science ®Google Scholar
• Blot , W J , Li , J Y , Taylor , P R , Guo , W Dawsey , S . 1993 . Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population . J Natl Cancer Inst , 85 : 1483 – 1492 .
   PubMed Web of Science ®Google Scholar
• Li , J Y , Taylor , P R , Li , B , Dawsey , S Wang , G Q . 1993 . Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia . J Natl Cancer Inst , 85 : 1492 – 1498 .
   PubMed Web of Science ®Google Scholar
• Clark , L C , Combs , G F Jr , Turnbull , BW , Slate , EH Chalker , DK . 1996 . Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. Nutritional Prevention of Cancer Study Group . JAMA , 276 : 1957 – 1963 .
   PubMed Web of Science ®Google Scholar
• Clark , L C , Dalkin , B , Krongrad , A and Combs , G F Jr . 1998 . Turnbull BW, et al.: Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial . Br J Urol , 81 : 730 – 734 .
   PubMedGoogle Scholar
• Clark , L C and Jacobs , E T . 1998 . Environmental selenium and cancer: risk or protection? . Cancer Epidemiol Biomarkers Prev , 7 : 847 – 848 . 851–852
   PubMed Web of Science ®Google Scholar
• Duffield-Lillico , A J , Reid , M E , Turnbull , B W , Combs , G F Jr Slate , E H . 2002 . Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial . Cancer Epidemiol Biomarkers Prev , 11 : 630 – 639 .
   PubMed Web of Science ®Google Scholar
• Duffield-Lillico , A J , Dalkin , B L , Reid , M E , Turnbull , B W Slate , E H . 2003 . Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial . BJU Int , 91 : 608 – 612 .
   PubMed Web of Science ®Google Scholar
• Combs , G F Jr . 2004 . Status of selenium in prostate cancer prevention . Br J Cancer , 91 : 195 – 199 .
   PubMed Web of Science ®Google Scholar
• Nelson , M A , Reid , M , Duffield-Lillico , A J and Marshall , J R . 2002 . Prostate cancer and selenium . Urol Clin North Am , 29 : 67 – 70 .
   PubMed Web of Science ®Google Scholar
• Reid , M E , Duffield-Lillico , A J , Garland , L , Turnbull , B W Clark , L C . 2002 . Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial . Cancer Epidemiol Biomarkers Prev , 11 : 1285 – 1291 .
   PubMed Web of Science ®Google Scholar
• Burton , G W , Cheeseman , K H , Doba , T , Ingold , K U and Slater , T F . 1983 . Vitamin E as an antioxidant in vitro and in vivo . Ciba Found Symp , 101 : 4 – 18 .
   PubMedGoogle Scholar
• Lippman , S M , Goodman , P J , Klein , E A , Parnes , H L Thompson , I M Jr . 2005 . Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT) . J Natl Cancer Inst , 97 : 94 – 102 .
   PubMed Web of Science ®Google Scholar
• Traber , M G , Frei , B and Beckman , J S . 2008 . Vitamin E revisited: do new data validate benefits for chronic disease prevention? . Curr Opin Lipidol , 19 : 30 – 38 .
   PubMed Web of Science ®Google Scholar
• Nakagawa , K , Shibata , A , Yamashita , S , Tsuzuki , T Kariya , J . 2007 . In vivo angiogenesis is suppressed by unsaturated vitamin E, tocotrienol . J Nutr , 137 : 1938 – 1943 .
   PubMed Web of Science ®Google Scholar
• Crispen , P L , Uzzo , R G , Golovine , K , Makhov , P Pollack , A . 2007 . Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention . Prostate , 67 : 582 – 590 .
   PubMed Web of Science ®Google Scholar
• Weiser , H , Vecchi , M and Schlachter , M . 1986 . Stereoisomers of alpha-tocopheryl acetate. IV. USP units and alpha-tocopherol equivalents of all-rac-, 2-ambo- and RRR-alpha-tocopherol evaluated by simultaneous determination of resorption-gestation, myopathy and liver storage capacity in rats . Int J Vitam Nutr Res , 56 : 45 – 56 .
   PubMed Web of Science ®Google Scholar
• Ju , J , Hao , X , Lee , M J , Lambert , J D Lu , G . 2009 . A gamma-tocopherol-rich mixture of tocopherols inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sulfate sodium-treated mice . Cancer Prev Res (Phila Pa) , 2 : 143 – 152 .
   PubMed Web of Science ®Google Scholar
• Brigelius-Flohe , R and Traber , M G . 1999 . Vitamin E: function and metabolism . Faseb J , 13 : 1145 – 1155 .
   PubMed Web of Science ®Google Scholar
• Traber , M G and Atkinson , J . 2007 . Vitamin E, antioxidant and nothing more . Free Radic Biol Med , 43 : 4 – 15 .
   PubMed Web of Science ®Google Scholar
• Christen , S , Woodall , A A , Shigenaga , M K , Southwell-Keely , P T Duncan , M W . 1997 . gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications . Proc Natl Acad Sci USA , 94 : 3217 – 3222 .
   PubMed Web of Science ®Google Scholar
• Dietrich , M , Traber , M G , Jacques , P F , Cross , C E Hu , Y . 2006 . Does gamma-tocopherol play a role in the primary prevention of heart disease and cancer? a review . J Am Coll Nutr , 25 : 292 – 299 .
   PubMed Web of Science ®Google Scholar
• Azzi , A . 2007 . Molecular mechanism of alpha-tocopherol action . Free Radic Biol Med , 43 : 16 – 21 .
   PubMed Web of Science ®Google Scholar
• Panel on Dietary Antioxidants and Related Compounds . 2000 . Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. , Washington, DC : Institute of Medicine .
   Google Scholar
• XX , N IH and Vitamin , E . 2008 . National Institutes of Health Office of Dietary Supplements http://ods.od.nih.gov/factsheets/vitamine.asp Accessed October 21
   Google Scholar
• Ekstrand-Hammarstrom , B , Osterlund , C , Lilliehook , B and Bucht , A . 2007 . Vitamin E down-modulates mitogen-activated protein kinases, nuclear factor-kappaB and inflammatory responses in lung epithelial cells . Clin Exp Immunol , 147 : 359 – 369 .
   PubMed Web of Science ®Google Scholar
• Zhang , Y , Ni , J , Messing , E M , Chang , E Yang , C R . 2002 . Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells . Proc Natl Acad Sci USA , 99 : 7408 – 7413 .
   PubMed Web of Science ®Google Scholar
• Thompson , T A and Wilding , G . 2003 . Androgen antagonist activity by the antioxidant moiety of vitamin E, 2,2,5,7,8-pentamethyl-6-chromanol in human prostate carcinoma cells . Mol Cancer Ther , 2 : 797 – 803 .
   PubMed Web of Science ®Google Scholar
• Shiau , C W , Huang , J W , Wang , D S , Weng , J R Yang , C C . 2006 . Alpha-tocopheryl succinate induces apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 function . J Biol Chem , 281 : 11819 – 11825 .
   PubMed Web of Science ®Google Scholar
• Sigounas , G , Anagnostou , A and Steiner , M . 1997 . dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells . Nutr Cancer , 28 : 30 – 35 .
   PubMed Web of Science ®Google Scholar
• Israel , K , Sanders , B G and Kline , K . 1995 . RRR-alpha-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways . Nutr Cancer , 24 : 161 – 169 .
   PubMed Web of Science ®Google Scholar
• Ni , J , Chen , M , Zhang , Y , Li , R Huang , J . 2003 . Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery . Biochem Biophys Res Commun , 300 : 357 – 363 .
   PubMed Web of Science ®Google Scholar
• Zhang , M , Altuwaijri , S and Yeh , S . 2004 . RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness . Oncogene , 23 : 3080 – 3088 .
   PubMed Web of Science ®Google Scholar
• Rocksen , D , Ekstrand-Hammarstrom , B , Johansson , L and Bucht , A . 2003 . Vitamin E reduces transendothelial migration of neutrophils and prevents lung injury in endotoxin-induced airway inflammation . Am J Respir Cell Mol Biol , 28 : 199 – 207 .
   PubMed Web of Science ®Google Scholar
• Rocksen , D , Koch , B , Sandstrom , T and Bucht , A . 2004 . Lung effects during a generalized Shwartzman reaction and therapeutic intervention with dexamethasone or vitamin E . Shock , 22 : 482 – 490 .
   PubMed Web of Science ®Google Scholar
• Knekt , P , Aromaa , A , Maatela , J , Aaran , R K Nikkari , T . 1988 . Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up . Am J Epidemiol , 127 : 28 – 41 .
   PubMed Web of Science ®Google Scholar
• Hsing , A W , Comstock , G W , Abbey , H and Polk , B F . 1990 . Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer . J Natl Cancer Inst , 82 : 941 – 946 .
   PubMed Web of Science ®Google Scholar
• Eichholzer , M , Stahelin , H B , Gey , K F , Ludin , E and Bernasconi , F . 1996 . Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study . Int J Cancer , 66 : 145 – 150 .
   PubMed Web of Science ®Google Scholar
• Rohan , T E , Howe , G R , Burch , J D and Jain , M . 1995 . Dietary factors and risk of prostate cancer: a case-control study in Ontario, Canada . Cancer Causes Control , 6 : 145 – 154 .
   PubMed Web of Science ®Google Scholar
• Hartman , T J , Albanes , D , Pietinen , P , Hartman , A M Rautalahti , M . 1998 . The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study . Cancer Epidemiol Biomarkers Prev , 7 : 335 – 340 .
   PubMed Web of Science ®Google Scholar
• Weinstein , S J , Wright , M E , Pietinen , P , King , I Tan , C . 2005 . Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study . J Natl Cancer Inst , 97 : 396 – 399 .
   PubMed Web of Science ®Google Scholar
• Comstock , G W , Helzlsouer , K J and Bush , T L . 1991 . Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland . Am J Clin Nutr , 53 ( 1 Suppl ) : 260S – 264S .
   PubMed Web of Science ®Google Scholar
• Heinonen , O P , Albanes , D , Virtamo , J , Taylor , P R Huttunen , J K . 1998 . Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial . J Natl Cancer Inst , 90 : 440 – 446 .
   PubMed Web of Science ®Google Scholar
• The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers . 1994 . The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group . N Engl J Med , 330 : 1029 – 1035 .
   PubMedGoogle Scholar
• Zu , K and Ip , C . 2003 . Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells . Cancer Res , 63 : 6988 – 6995 .
   PubMed Web of Science ®Google Scholar
• Vraka , P S , Drouza , C , Rikkou , M P , Odysseos , A D and Keramidas , A D . 2006 . Synthesis and study of the cancer cell growth inhibitory properties of alpha-, gamma-tocopheryl and gamma-tocotrienyl 2-phenylselenyl succinates . Bioorg Med Chem , 14 : 2684 – 2696 .
   PubMed Web of Science ®Google Scholar
• Peters , U , Littman , A J , Kristal , A R , Patterson , R E Potter , J D . 2008 . Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and Lifestyle (VITAL) study cohort . Cancer Causes Control , 19 : 75 – 87 .
   PubMed Web of Science ®Google Scholar
• Hercberg , S , Galan , P , Preziosi , P , Bertrais , S Mennen , L . 2004 . The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. . Arch Intern Med , 164 : 2335 – 2342 .
   PubMed Web of Science ®Google Scholar
• Meyer , F , Galan , P , Douville , P , Bairati , I Kegle , P . 2005 . Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. . Int J Cancer , 116 : 182 – 186 .
   PubMed Web of Science ®Google Scholar
• Klein , E A , Thompson , I M , Lippman , S M , Goodman , P J Albanes , D . 2003 . SELECT: the selenium and vitamin E cancer prevention trial . Urol Oncol , 21 : 59 – 65 .
   PubMed Web of Science ®Google Scholar
• Hoque , A , Albanes , D , Lippman , S M , Spitz , M R Taylor , P R . 2001 . Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT) . Cancer Causes Control , 12 : 627 – 633 .
   PubMed Web of Science ®Google Scholar
• Sano , M , Ernesto , C , Thomas , R G , Klauber , M R Schafer , K . 1997 . A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease: the Alzheimer's Disease Cooperative Study . N Engl J Med , 336 : 1216 – 1222 .
   PubMed Web of Science ®Google Scholar
• 2001 . A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8 . Arch Ophthalmol , 119 : 1417 – 1436 .
   PubMed Web of Science ®Google Scholar
• Lee , J J , Lieberman , R , Sloan , J A , Piantadosi , S and Lippman , S M . 2001 . Design considerations for efficient prostate cancer chemoprevention trials . Urology , 57 ( 1Suppl ) : 205 – 212 .
   PubMed Web of Science ®Google Scholar
• Cook , E D , Moody-Thomas , S , Anderson , K B , Campbell , R Hamilton , S J . 2005 . Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT) . Clin Trials , 2 : 436 – 442 .
   PubMed Web of Science ®Google Scholar
• Thompson , I M , Pauler , D K , Goodman , P J , Tangen , C M Lucia , M S . 2004 . : Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter . N Engl J Med , 350 : 2239 – 2246 .
   PubMed Web of Science ®Google Scholar
• Lippman , S M , Klein , E A , Goodman , P J , Lucia , M S Thompson , I M . 2009 . Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) . JAMA , 301 : 39 – 51 .
   PubMed Web of Science ®Google Scholar
• Hughes , G H , Cutter , G , Donahue , R , Friedman , G D Hulley , S . 1987 . Recruitment in the Coronary Artery Disease Risk Development in Young Adults (Cardia) Study . Control Clin Trials , 8 ( 4 Suppl ) : 68S – 73S .
   PubMedGoogle Scholar
• Hague , W E , Gebski , V J and Keech , A C . 2003 . Recruitment to randomised studies . Med J Aust , 178 : 579 – 581 .
   PubMed Web of Science ®Google Scholar
• Blanton , S , Morris , D M , Prettyman , M G , McCulloch , K Redmond , S . 2006 . Lessons learned in participant recruitment and retention: the EXCITE trial . Phys Ther , 86 : 1520 – 1533 .
   PubMed Web of Science ®Google Scholar
• Mills , K M , Stewart , A L , King , A C , Roitz , K Sepsis , P G . 1996 . Factors associated with enrollment of older adults into a physical activity promotion program . J Aging Health , 8 : 96 – 113 .
   PubMed Web of Science ®Google Scholar
• Brandt , C A , Argraves , S , Money , R , Ananth , G Trocky , N M . 2006 . Informatics tools to improve clinical research study implementation . Contemp Clin Trials , 27 : 112 – 122 .
   PubMed Web of Science ®Google Scholar
• Vickers , A J . 2007 . How to improve accrual to clinical trials of symptom control 2: design issues . J Soc Integr Oncol , 5 : 61 – 64 .
   PubMedGoogle Scholar
• Getz , K A , Wenger , J , Campo , R A , Seguine , E S and Kaitin , K I . 2008 . Assessing the impact of protocol design changes on clinical trial performance . Am J Ther , 15 : 450 – 457 .
   PubMed Web of Science ®Google Scholar
• Gorelick , P B , Harris , Y , Burnett , B and Bonecutter , F J . 1998 . The recruitment triangle: reasons why African Americans enroll, refuse to enroll, or voluntarily withdraw from a clinical trial. An interim report from the African-American Antiplatelet Stroke Prevention Study (AAASPS) . J Natl Med Assoc , 90 : 141 – 145 .
   PubMed Web of Science ®Google Scholar
• Adams-Campbell , L L , Ahaghotu , C , Gaskins , M , Dawkins , F W Smoot , D . 2004 . Enrollment of African Americans onto clinical treatment trials: study design barriers . J Clin Oncol , 22 : 730 – 734 .
   PubMed Web of Science ®Google Scholar
• Traber , M G . 2008 . Vitamin E and K interactions—a 50-year-old problem . Nutr Rev , 66 : 624 – 629 .
   PubMed Web of Science ®Google Scholar
• Stranges , S , Marshall , J R , Natarajan , R , Donahue , R P Trevisan , M . 2007 . Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial . Ann Intern Med , 147 : 217 – 223 .
   PubMed Web of Science ®Google Scholar
• Bleys , J , Navas-Acien , A and Guallar , E . 2007 . Selenium and diabetes: more bad news for supplements . Ann Intern Med , 147 : 271 – 272 .
   PubMed Web of Science ®Google Scholar
• Bleys , J , Navas-Acien , A and Guallar , E . 2007 . Serum selenium and diabetes in U.S. adults . Diabetes Care , 30 : 829 – 834 .
   PubMed Web of Science ®Google Scholar
• Waters , D J , Shen , S , Glickman , L T , Cooley , D M Bostwick , D G . 2005 . Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model . Carcinogenesis , 26 : 1256 – 1262 .
   PubMed Web of Science ®Google Scholar
• Mertz , W . 1981 . The essential trace elements . Science , 213 : 1332 – 1338 .
   PubMed Web of Science ®Google Scholar
• Hatfield , D L and Gladyshev , V N . 2009 . The outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) reveals the need for better understanding of selenium biology . Mol Interv , 9 : 18 – 21 .
   PubMed Web of Science ®Google Scholar
• Ip , C , Thompson , H J , Zhu , Z and Ganther , H E . 2000 . In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention . Cancer Res , 60 : 2882 – 2886 .
   PubMed Web of Science ®Google Scholar
• El-Bayoumy , K . 2009 . The negative results of the SELECT study do not necessarily discredit the selenium-cancer prevention hypothesis . Nutr Cancer , 61 : 285 – 286 .
   PubMed Web of Science ®Google Scholar
• Patterson , B H and Levander , O A . 1997 . Naturally occurring selenium compounds in cancer chemoprevention trials: a workshop summary . Cancer Epidemiol Biomarkers Prev , 6 : 63 – 69 .
   PubMed Web of Science ®Google Scholar
• Bekaert , B and Rayman , M P . 2009 . Plasma selenium concentration and prostate cancer risk . Am J Clin Nutr , 89 : 1276 – 1277 .
   PubMed Web of Science ®Google Scholar
• Li , H , Kantoff , P W , Giovannucci , E , Leitzmann , M F Gaziano , J M . 2005 . Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer . Cancer Res , 65 : 2498 – 2504 .
   PubMed Web of Science ®Google Scholar
• Chan , J M , Oh , W K , Xie , W , Regan , M M Stampfer , M J . 2009 . Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer . J Clin Oncol , 27 : 3577 – 3583 .
   PubMed Web of Science ®Google Scholar
• Li , J D and Mehrotra , D V . 2008 . Gatekeeping testing via adaptive alpha allocation . Biom J , 50 : 704 – 715 .
   PubMed Web of Science ®Google Scholar
• Freemantle , N . 2001 . Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic? . BMJ , 322 : 989 – 991 .
   PubMed Web of Science ®Google Scholar
• O’Neill , R T . 1997 . Secondary endpoints cannot be validly analyzed if the primary endpoint does not demonstrate clear statistical significance . Control Clin Trials , 18 : 550 – 556 . 561–567
   PubMedGoogle Scholar
• Davis , C E . 1997 . Secondary endpoints can be validly analyzed, even if the primary endpoint does not provide clear statistical significance . Control Clin Trials , 18 : 557 – 560 . 561–567
   PubMedGoogle Scholar
• Allen , N E and Key , T J . 2009 . Prostate cancer: neither vitamin E nor selenium prevent prostate cancer . Nat Rev Urol , 6 : 187 – 188 .
   PubMed Web of Science ®Google Scholar
• Lonn , E , Bosch , J , Yusuf , S , Sheridan , P Pogue , J . 2005 . Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial . JAMA , 293 : 1338 – 1347 .
   PubMed Web of Science ®Google Scholar
• Gaziano , J M , Glynn , R J , Christen , W G , Kurth , T Belanger , C . 2009 . Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians’ Health Study II randomized controlled trial . JAMA , 301 : 52 – 62 .
   PubMed Web of Science ®Google Scholar
• Woodson , K , Tangrea , J A , Barrett , M J , Virtamo , J Taylor , P R . 1999 . Serum alpha-tocopherol and subsequent risk of lung cancer among male smokers . J Natl Cancer Inst , 91 : 1738 – 1743 .
   PubMedGoogle Scholar
• Jiang , Q , Elson-Schwab , I , Courtemanche , C and Ames , B N . 2000 . gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells . Proc Natl Acad Sci USA , 97 : 11494 – 11499 .
   PubMed Web of Science ®Google Scholar
• Newmark , H L , Huang , M T and Reddy , B S . 2006 . Mixed tocopherols inhibit azoxymethane-induced aberrant crypt foci in rats . Nutr Cancer , 56 : 82 – 85 .
   PubMed Web of Science ®Google Scholar
• Jiang , Q and Ames , B N . 2003 . Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats . Faseb J , 17 : 816 – 822 .
   PubMed Web of Science ®Google Scholar
• Hensley , K , Benaksas , E J , Bolli , R , Comp , P Grammas , P . 2004 . New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine . Free Radic Biol Med , 36 : 1 – 15 .
   PubMed Web of Science ®Google Scholar
• Reiter , E , Jiang , Q and Christen , S . 2007 . Anti-inflammatory properties of alpha- and gamma-tocopherol . Mol Aspects Med , 28 : 668 – 691 .
   PubMed Web of Science ®Google Scholar
• Huang , H Y , Alberg , A J , Norkus , E P , Hoffman , S C Comstock , G W . 2003 . Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer . Am J Epidemiol , 157 : 335 – 344 .
   PubMed Web of Science ®Google Scholar
• Handelman , G J , Machlin , L J , Fitch , K , Weiter , J J and Dratz , E A . 1985 . Oral alpha-tocopherol supplements decrease plasma gamma-tocopherol levels in humans . J Nutr , 115 : 807 – 813 .
   PubMed Web of Science ®Google Scholar
• White , E , Kristal , A R , Shikany , J M , Wilson , A C Chen , C . 2001 . Correlates of serum alpha- and gamma-tocopherol in the Women's Health Initiative . Ann Epidemiol , 11 : 136 – 144 .
   PubMed Web of Science ®Google Scholar
• Lehmann , J , Rao , D D , Canary , J J and Judd , J T . 1988 . Vitamin E and relationships among tocopherols in human plasma, platelets, lymphocytes, and red blood cells . Am J Clin Nutr , 47 : 470 – 474 .
   PubMed Web of Science ®Google Scholar
• Dieber-Rotheneder , M , Puhl , H , Waeg , G , Striegl , G and Esterbauer , H . 1991 . Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation . J Lipid Res , 32 : 1325 – 1332 .
   PubMed Web of Science ®Google Scholar
• Kirsh , V A , Hayes , R B , Mayne , S T , Chatterjee , N Subar , A F . 2006 . Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk . J Natl Cancer Inst , 98 : 245 – 254 .
   PubMed Web of Science ®Google Scholar
• Zingg , J M , Azzi , A and Meydani , M . 2008 . Genetic polymorphisms as determinants for disease-preventive effects of vitamin E . Nutr Rev , 66 : 406 – 414 .
   PubMed Web of Science ®Google Scholar
• Wright , M E , Peters , U , Gunter , M J , Moore , S C Lawson , K A . 2009 . Association of variants in two vitamin E transport genes with circulating vitamin E concentrations and prostate cancer risk . Cancer Res , 69 : 1429 – 1438 .
   PubMed Web of Science ®Google Scholar
• Tsavachidou , D , McDonnell , T J , Wen , S , Wang , X Vakar-Lopez , F . 2009 . Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer . J Natl Cancer Inst , 101 : 306 – 320 .
   PubMedGoogle Scholar
• Jiang , Q , Lykkesfeldt , J , Shigenaga , M K , Shigeno , E T Christen , S . 2002 . Gamma-tocopherol supplementation inhibits protein nitration and ascorbate oxidation in rats with inflammation . Free Radic Biol Med , 33 : 1534 – 1542 .
   PubMed Web of Science ®Google Scholar
• Campbell , S E , Stone , W L , Lee , S , Whaley , S Yang , H . 2006 . Comparative effects of RRR-alpha- and RRR-gamma-tocopherol on proliferation and apoptosis in human colon cancer cell lines . BMC Cancer , 6 : 13
   PubMed Web of Science ®Google Scholar
• Suh , N , Paul , S , Lee , H J , Ji , Y Lee , M J . 2007 . Mixed tocopherols inhibit N-methyl-N-nitrosourea-induced mammary tumor growth in rats . Nutr Cancer , 59 : 76 – 81 .
   PubMed Web of Science ®Google Scholar